Jack Boren
Managing Partner @ EPIC Ventures
Salt Lake City, United States
Jack Boren is a Managing Partner at EPIC Ventures. He attended the University of Utah.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Jack Boren invests in
Stages Jack Boren invests in
Countries Jack Boren invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 5 (22%)
- Software 4 (17%)
- Biotechnology 4 (17%)
- Information Technology 4 (17%)
- Hospital 3 (13%)
Stage
- Series A 7 (30%)
- Series B 5 (22%)
- Series C 4 (17%)
- Seed 2 (9%)
- Series D 2 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| CaLycia Bioscience is a biotechnology startup that develops myeloid-based cell therapy for treating tumors such as glioblastoma. | $400K / Pre-Seed / Jan 15, 2026 | ||
| Noetik is an AI-native biotechnology company. Noetik leverages in advanced machine learning methods to discover and develop cancer immunotherapies. | $40M / Series A / Aug 28, 2024 | ||
| Redo develops a free return automation application for brand owners. It turns refunds into exchanges or store credit. It also automates the return process to operate under preferences and helps clients transform their returns center into a profit center. Its package protection simplifies claims management with an all-in-one customer portal, makingit easy to offer, track, and resolve claims. | $24M / Series A / Aug 20, 2024 | ||
| Videra Health often provides vital signs, such as heart rate, blood pressure, etc. The richness of the whole can drive insight into the relationship with the providers, medications, and treatment programs. Videra Health aims to empower patients and healthcare providers through AI-powered care-related analytics and insights to improve patientengagement, develop treatment plans, track symptoms, evaluate progress, monitor medication responses and safety, and achieve positive outcomes. | $5.6M / Seed / May 21, 2024 | ||
| Unlearn.AI is a biotech AI company that develops a digital twin service for clinical trials. Digital twins enhance healthcare by assessing health risks before a disease manifests its symptoms, according to some experts. Unlearn brings together a world-class team of experts across pharma, medtech, machine learning, and business who share a visionof using machine learning and biostatistics to improve clinical trials for the benefit of patients and sponsors.Unlearn invented their TwinRCT solution to enable biopharma partners to run faster, more successful clinical trials. A TwinRCT is a randomized trial that uses machine learning to achieve a higher probability of success with a smaller number of patients. As in a traditional RCT, patients are randomized to a treatment group and a control group, but, unlike a traditional trial, a prognostic digital twin is created for every patient using a machine learning model trained on historical data. The treatment effects for the primary and secondary outcomes can all be estimated from the trial with greater precision after correcting for a prognostic score derived for each patient's digital twin.TwinRCTs provide a scientifically-sound method for using deep learning and historical patient data to improve clinical trials. | $50M / Series C / Feb 08, 2024 | ||
| Culmination Bio is a startup that is developing a disease-independent patient data intelligence platform. | $10M / Series A / Nov 30, 2023 | ||
| HealthJoy is a benefits experience platform helping companies save money while improving employee satisfaction. Through personalized guidance and AI technology, it empowers employees to better use and understand their benefits. The result is happier employees, increased cost containment, and fewer questions for HR.HealthJoy integrates a client’sexisting benefits to deliver each employee a personalized digital benefits wallet that keeps benefits top-of-mind. Employees also gain on-demand access to online medical consultations, live healthcare concierges, Rx savings, and much more. HealthJoy empowers employees to become educated healthcare shoppers and fundamentally changes healthcare dynamics. | $60M / Series D / Oct 27, 2022 | ||
| GuideCX offers everything you need to provide a self-serve implementation experience in one versatile and dynamic package. Use templates to automate and reproduce repetitive processes that involve customers and 3rd parties. (i.e. Onboarding, Procurement...). Automated communication provides updates and maintains accountability. By improving theefficiency and transparency of the onboarding process, you can do more with less when you use GuideCX. | $25M / Series B / Feb 02, 2022 | ||
| Appdetex solves business problems related to digital risks. With deep roots in intellectual property law and applying technical innovation to securing brands, Appdetex is dedicated to the success of brand protection and security professionals and serves the world’s most trusted financial institutions, media platforms, and top-of-the-charts gamingand software companies.Founded in 2012 by brand protection veterans, the Appdetex team applies decades of experience in digital risk mitigation to your brand challenges. Disrupting highly organized, automated, and widespread systems of abuse requires technology and expertise to ensure your brand can continue to deliver an authentic experience to your customers.It was founded in 2012 and headquartered in Boise, Idaho. | $12.2M / Series C / Jan 28, 2021 | ||
| GuideCX offers everything you need to provide a self-serve implementation experience in one versatile and dynamic package. Use templates to automate and reproduce repetitive processes that involve customers and 3rd parties. (i.e. Onboarding, Procurement...). Automated communication provides updates and maintains accountability. By improving theefficiency and transparency of the onboarding process, you can do more with less when you use GuideCX. | $10M / Series A / Nov 12, 2020 | ||
| See all 23 investments → | |||
Co-Investors
About EPIC Ventures
EPIC Ventures is a premier early stage software and Internet infrastructure venture firm whose mission is to back entrepreneurs and companies positioned to lead the information economy of tomorrow. We bring the collective operational and financial experience of our partnership, our world class advisors, and our extensive network of technology industry contacts to engage and ensure our portfolio's success. Strategically located in Salt Lake City, we're never more than a short flight from any of the geographies we invest in.
EPIC Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chris Stone
Advisor
|
|||
Craig Jeppson
Principal
|
|||
Charles Fisher
Venture Partner
|
|||
Geoff Woolley
Venture Partners
|
|||
|
Jack Boren
Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jack Boren invest in?
Jack Boren invests primarily in Health Care, Software and Biotechnology startups, most often at Series A and Series B stage. Most of the 23 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jack Boren?
Public channels for Jack Boren include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jack Boren last invest?
The most recent investment recorded for Jack Boren closed in Jan 2026. Shizune tracks 23 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
